This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1rgq
From Proteopedia
(New page: 200px<br /><applet load="1rgq" size="450" color="white" frame="true" align="right" spinBox="true" caption="1rgq, resolution 2.90Å" /> '''M9A HCV Protease com...) |
|||
| Line 1: | Line 1: | ||
| - | [[Image:1rgq.gif|left|200px]]<br /><applet load="1rgq" size=" | + | [[Image:1rgq.gif|left|200px]]<br /><applet load="1rgq" size="350" color="white" frame="true" align="right" spinBox="true" |
caption="1rgq, resolution 2.90Å" /> | caption="1rgq, resolution 2.90Å" /> | ||
'''M9A HCV Protease complex with pentapeptide keto-amide inhibitor'''<br /> | '''M9A HCV Protease complex with pentapeptide keto-amide inhibitor'''<br /> | ||
==Overview== | ==Overview== | ||
| - | A series of novel peptidyl-alpha-ketoamide compounds were evaluated as | + | A series of novel peptidyl-alpha-ketoamide compounds were evaluated as inhibitors of the deltaNS3-NS4A serine protease from the hepatitis C virus. These peptidyl-alpha-ketoamide inhibitors with Ki values ranging from 0.17 nM to 5.6 microM exhibited slow-binding inhibition. Kinetic studies established one-step kinetic mechanisms and dissociation rate constants in the 3-7 x 10(-5) s(-1) range for these compounds. The association rate constants, which ranged from 10 to 263,000 M(-1) s(-1), were responsible for the greater than four order of magnitude overall binding affinity range exhibited by this series. An X-ray crystal structure of a protease-inhibitor complex revealed an unusual interaction between the oxyanion of the adduct and the protein as well as a significant movement in the S1' region of the protein loop comprising residues 35-42. These results are quite different from peptidyl-alpha-ketoacid inhibition of HCV protease, which reportedly undergoes no notable conformational changes and proceeds with a two-step slow-binding kinetic mechanism. |
==About this Structure== | ==About this Structure== | ||
| - | 1RGQ is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Hepatitis_c_virus Hepatitis c virus] with ZN and AKP as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Hepacivirin Hepacivirin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.98 3.4.21.98] Full crystallographic information is available from [http:// | + | 1RGQ is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Hepatitis_c_virus Hepatitis c virus] with <scene name='pdbligand=ZN:'>ZN</scene> and <scene name='pdbligand=AKP:'>AKP</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Hepacivirin Hepacivirin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.98 3.4.21.98] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1RGQ OCA]. |
==Reference== | ==Reference== | ||
| Line 14: | Line 14: | ||
[[Category: Hepatitis c virus]] | [[Category: Hepatitis c virus]] | ||
[[Category: Protein complex]] | [[Category: Protein complex]] | ||
| - | [[Category: Kati, W | + | [[Category: Kati, W M.]] |
| - | [[Category: Klaus, J | + | [[Category: Klaus, J L.]] |
[[Category: Kohlbrenner, W.]] | [[Category: Kohlbrenner, W.]] | ||
[[Category: Liu, Y.]] | [[Category: Liu, Y.]] | ||
[[Category: Molla, A.]] | [[Category: Molla, A.]] | ||
| - | [[Category: Richardson, P | + | [[Category: Richardson, P L.]] |
[[Category: Saldivar, A.]] | [[Category: Saldivar, A.]] | ||
| - | [[Category: Stoll, V | + | [[Category: Stoll, V S.]] |
[[Category: AKP]] | [[Category: AKP]] | ||
[[Category: ZN]] | [[Category: ZN]] | ||
[[Category: hepatitis c virus protease keto amide peptide inhibitor]] | [[Category: hepatitis c virus protease keto amide peptide inhibitor]] | ||
| - | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:50:43 2008'' |
Revision as of 12:50, 21 February 2008
|
M9A HCV Protease complex with pentapeptide keto-amide inhibitor
Overview
A series of novel peptidyl-alpha-ketoamide compounds were evaluated as inhibitors of the deltaNS3-NS4A serine protease from the hepatitis C virus. These peptidyl-alpha-ketoamide inhibitors with Ki values ranging from 0.17 nM to 5.6 microM exhibited slow-binding inhibition. Kinetic studies established one-step kinetic mechanisms and dissociation rate constants in the 3-7 x 10(-5) s(-1) range for these compounds. The association rate constants, which ranged from 10 to 263,000 M(-1) s(-1), were responsible for the greater than four order of magnitude overall binding affinity range exhibited by this series. An X-ray crystal structure of a protease-inhibitor complex revealed an unusual interaction between the oxyanion of the adduct and the protein as well as a significant movement in the S1' region of the protein loop comprising residues 35-42. These results are quite different from peptidyl-alpha-ketoacid inhibition of HCV protease, which reportedly undergoes no notable conformational changes and proceeds with a two-step slow-binding kinetic mechanism.
About this Structure
1RGQ is a Protein complex structure of sequences from Hepatitis c virus with and as ligands. Active as Hepacivirin, with EC number 3.4.21.98 Full crystallographic information is available from OCA.
Reference
Hepatitis C NS3 protease inhibition by peptidyl-alpha-ketoamide inhibitors: kinetic mechanism and structure., Liu Y, Stoll VS, Richardson PL, Saldivar A, Klaus JL, Molla A, Kohlbrenner W, Kati WM, Arch Biochem Biophys. 2004 Jan 15;421(2):207-16. PMID:14984200
Page seeded by OCA on Thu Feb 21 14:50:43 2008
